Perceptions of Cigarette Smoking in Young Adults (PRISM)
Status
Conditions
Treatments
Details and patient eligibility
About
This study focuses on menthol (n = 125) and non-menthol (n = 125) smoking young adults (YAs; defined here as ages 18 to 26).
Full description
The study will occur in three phases.
In session 1 of Phase 1, participants will engage in ad libitum smoking session of one's preferred cigarette brand (menthol or non-menthol). In session 2, participants will take several puffs each of a commercially available menthol and non-menthol cigarette (i.e., Camel Crush) and complete a complete a series of pre-post smoking questionnaires, and in Session 3 participants will complete a computerized task to measure perceptions of cigarette smoking. For the computerized task, participants will be able to "win" points toward earning puffs of a cigarette and will be able to smoke puffs earned. Participants will be asked to abstain from smoking for at least 12 hours before each in-person visit.
Phase 2 participants will engage in 14 days of surveys they will complete on their cell to measure different aspects of smoking behavior. These surveys will happen twice a day at random times.
For phase 3, participants will complete an assessment of smoking behavior and related factors 6-months after the baseline assessment either in-person, in the laboratory, or via telephone or online (if in-person follow-up is not viable).
The order in which phases occur differed was a result of COVID-19 restrictions on data collection. For some participants, they started EMA first and then began laboratory data collection when in-person was allowed. For others, they started laboratory data collection when COVID restrictions were lifted. Thus, the participant flow may appear unbalanced.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Ages 18-26
- Currently smoke cigarettes "everyday" or "somedays"
- A strong preference for menthol or non-menthol cigarettes
- able to read and understand the consent form
- willingness to abstain from nicotine or tobacco products for at least 12 hours prior to smoking sessions
Exclusion criteria
- Current use of nicotine replacement therapy
- Pregnant or planning to become pregnant; or breastfeeding
- self-reported diagnosis of lung disease, including asthma, cystic fibrosis, or chronic obstructive pulmonary disease; or
- self-reported history of cardiac event or distress within the past 3-months
Trial design
Primary purpose
Allocation
Interventional model
Masking
199 participants in 2 patient groups
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal